|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$1.47 0.00 (0.00%) as of 4:30 Thu 8/11
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
103,891,000 |
| Market
Cap: |
152.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.47 - $1.47 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mott David M |
Director |
– • – |
2021-03-26 |
4 |
B |
$7.80 |
$274,817 |
D/D |
34,486 |
150,900 |
2.39 |
-16% |
|
| Bazemore Robert B |
President & CEO |
• • – |
2021-03-25 |
4 |
AS |
$7.85 |
$81,075 |
D/D |
(10,328) |
322,626 |
|
-21% |
|
| Mott David M |
Director |
– • – |
2021-03-25 |
4 |
B |
$7.98 |
$225,283 |
D/D |
28,231 |
116,414 |
2.39 |
-21% |
|
| Agarwal Shefali |
Chief Medical Officer |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$10,862 |
D/D |
(969) |
104,341 |
|
-23% |
|
| Vakiener Victoria |
Chief Commercial Officer |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$9,159 |
D/D |
(817) |
52,685 |
|
-23% |
|
| Bazemore Robert B |
President & CEO |
• • – |
2021-02-04 |
4 |
AS |
$11.21 |
$43,607 |
D/D |
(3,890) |
331,977 |
|
-23% |
|
| Ros Matthew |
See Remarks |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$10,022 |
D/D |
(894) |
83,188 |
|
-23% |
|
| Beaulieu Joseph |
Corporate Controller |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$2,545 |
D/D |
(227) |
13,431 |
|
-23% |
|
| Tombesi Paolo |
Chief Financial Officer |
• – – |
2021-02-04 |
4 |
AS |
$11.21 |
$11,445 |
D/D |
(1,021) |
53,465 |
|
-23% |
|
| Beaulieu Joseph |
Corporate Controller |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
7,700 |
13,658 |
|
- |
|
| Tombesi Paolo |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,041 |
54,486 |
|
- |
|
| Ros Matthew |
See Remarks |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,125 |
84,082 |
|
- |
|
| Bazemore Robert B |
President & CEO |
• • – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
87,500 |
335,867 |
|
- |
|
| Agarwal Shefali |
Chief Medical Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
29,583 |
105,310 |
|
- |
|
| Kutok Jeffery |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
28,645 |
56,057 |
|
- |
|
| Vakiener Victoria |
Chief Commercial Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
25,520 |
53,502 |
|
- |
|
| Agarwal Shefali |
Chief Medical Officer |
• – – |
2021-01-25 |
4 |
AS |
$11.41 |
$32,770 |
D/D |
(2,872) |
75,727 |
|
-31% |
|
| Bazemore Robert B |
President & CEO |
• • – |
2021-01-25 |
4 |
AS |
$11.41 |
$69,247 |
D/D |
(6,069) |
248,367 |
|
-31% |
|
| Vakiener Victoria |
Chief Commercial Officer |
• – – |
2021-01-25 |
4 |
AS |
$11.41 |
$6,835 |
D/D |
(599) |
27,982 |
|
-31% |
|
| Ros Matthew |
See Remarks |
• – – |
2021-01-25 |
4 |
AS |
$11.41 |
$32,770 |
D/D |
(2,872) |
55,957 |
|
-31% |
|
| Conroy Kevin T |
Director |
– • – |
2020-12-31 |
4 |
A |
$10.86 |
$11,121 |
D/D |
1,024 |
9,559 |
|
- |
|
| Mott David M |
Director |
– • – |
2020-12-31 |
4 |
A |
$10.86 |
$23,436 |
D/D |
2,158 |
88,183 |
|
- |
|
| Agarwal Shefali |
Chief Medical Officer |
• – – |
2020-12-03 |
4 |
AS |
$13.54 |
$34,148 |
D/D |
(2,522) |
76,089 |
|
-37% |
|
| Goldfischer Carl |
Director |
– • – |
2020-11-11 |
4 |
B |
$12.07 |
$60,350 |
D/D |
5,000 |
5,000 |
2.39 |
-33% |
|
| Conroy Kevin T |
Director |
– • – |
2020-09-30 |
4 |
A |
$11.93 |
$11,131 |
D/D |
933 |
8,535 |
|
- |
|
423 Records found
|
|
Page 4 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
